Myovant Sciences Ltd.
MYOVDelisted Mar 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679082
Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Myovant Sciences Ltd. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 89
- −20 vs. Q4 2021
- Shares held
- 30.0M
- −506.3K (−1.7%) vs. Q4 2021
- Total value
- $400.0M
- −$75.6M (−15.9%) vs. Q4 2021
- New holders
- 13
- 28 more added
- Sold out
- 33
- 28 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $27 |
| Q1 2026 | 1 | $27 |
| Q4 2025 | 1 | $27 |
| Q3 2025 | 1 | $27 |
| Q2 2025 | 1 | $27 |
| Q1 2025 | 1 | $27 |
| Q4 2024 | 1 | $27 |
| Q3 2024 | 1 | $27 |
| Q2 2024 | 1 | $27 |
| Q1 2024 | 1 | $27 |
| Q4 2023 | 1 | $27 |
| Q3 2023 | 1 | $27 |
| Q2 2023 | 1 | $27 |
| Q1 2023 | 2 | $27 |
| Q4 2022 | 118 | $1.12B |
| Q3 2022 | 98 | $511.5M |
| Q2 2022 | 91 | $369.3M |
| Q1 2022 | 89 | $400.0M |
| Q4 2021 | 110 | $475.6M |
| Q3 2021 | 105 | $677.6M |
| Q2 2021 | 108 | $736.6M |
| Q1 2021 | 104 | $623.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Myovant Sciences Ltd.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −18,586−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −18,370−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −17,892−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,561−100.0% | Sold out |
| Manteio Capital LLC | 0 | $0 | 0.00% | −16,326−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −16,028−100.0% | Sold out |
| Gladstone Institutional Advisory LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −12,676−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −10,456−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −10,357−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −10,340−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −8,760−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −6,804−100.0% | Sold out |
| Cornerstone Advisory, LLC | 0 | $0 | 0.00% | −6,300−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,803−100.0% | Sold out |
| Vestcor Inc | 0 | $0 | 0.00% | −1,695−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −1,080−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |